Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | CD22 binding agent | Other |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma | 1 | D008223 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109354 |
CONTENTS